Company Filing History:
Years Active: 2021
Title: Clemens Schmeitzl: Innovator in Enzymatic Detoxification
Introduction
Clemens Schmeitzl is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of enzymatic detoxification, particularly concerning zearalenone, a mycotoxin that poses risks to health.
Latest Patents
Clemens holds a patent for a polypeptide designed for the enzymatic detoxification of zearalenone. This invention involves a monooxygenase that converts the keto group in position 7 of zearalenone into an ester group. The patent details that the monooxygenase is an amino acid sequence selected from a specific group, with functional variants exhibiting a sequence identity of at least 60% to 90%. This innovation is crucial for improving food safety and reducing the impact of harmful toxins.
Career Highlights
Clemens Schmeitzl is associated with Erber Aktiengesellschaft, a company known for its focus on innovative solutions in the agricultural sector. His work has contributed to advancements in biochemistry and food safety, showcasing his expertise in the field.
Collaborations
Clemens has collaborated with notable colleagues, including Juan Antonio Torres Acosta and Gerhard Adam. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Clemens Schmeitzl's innovative work in enzymatic detoxification represents a significant advancement in addressing food safety challenges. His contributions through patents and collaborations continue to impact the field positively.